MIPOMERSEN for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 23 adverse event reports in the FDA FAERS database where MIPOMERSEN was used for Hypercholesterolaemia.
Most Reported Side Effects for MIPOMERSEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 67 | 33.7% | 1 | 4 |
| Hepatic enzyme increased | 48 | 24.1% | 0 | 5 |
| Injection site erythema | 48 | 24.1% | 1 | 3 |
| Influenza like illness | 36 | 18.1% | 0 | 3 |
| Injection site bruising | 31 | 15.6% | 0 | 3 |
| Fatigue | 26 | 13.1% | 0 | 2 |
| Nausea | 24 | 12.1% | 0 | 4 |
| Injection site discolouration | 23 | 11.6% | 1 | 1 |
| Injection site swelling | 23 | 11.6% | 0 | 0 |
| Injection site rash | 18 | 9.1% | 0 | 0 |
| Injection site reaction | 17 | 8.5% | 1 | 1 |
| Myalgia | 17 | 8.5% | 0 | 3 |
| Headache | 16 | 8.0% | 0 | 0 |
| Injection site pruritus | 15 | 7.5% | 0 | 1 |
| Drug dose omission | 14 | 7.0% | 1 | 1 |
Other Indications for MIPOMERSEN
Type iia hyperlipidaemia (138)
Product used for unknown indication (13)
Blood cholesterol increased (10)
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)